Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar deal with French drugmaker
Read more here.
Tel Aviv-based startup that uses AI to build digital models of the human immune system and diseases inks multi-million-dollar deal with French drugmaker
Read more here.